Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 30, 2021 Filed Aug 31, 2021 21:13 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionCommon Stock | 200 | $97.69 | $19,538.00 |
DisclosureSEC source: 0001127602-21-024594 · form4.xml · nonDerivative · entry 7 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 21:13 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
SaleCommon Stock | 100 | $134.75 | $13,475.00 |
DisclosureSEC source: 0001127602-21-024594 · form4.xml · nonDerivative · entry 6 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,375 Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 21:13 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionCommon Stock | 100 | $78.76 | $7,876.00 |
DisclosureSEC source: 0001127602-21-024594 · form4.xml · nonDerivative · entry 5 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 21:13 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
SaleCommon Stock | 300 | $134.75 | $40,425.00 |
DisclosureSEC source: 0001127602-21-024594 · form4.xml · nonDerivative · entry 4 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,375 Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 21:13 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionCommon Stock | 300 | $59.96 | $17,988.00 |
DisclosureSEC source: 0001127602-21-024594 · form4.xml · nonDerivative · entry 3 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 21:13 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
SaleCommon Stock | 3,640 | $134.75 | $490,490.36 |
DisclosureSEC source: 0001127602-21-024594 · form4.xml · nonDerivative · entry 2 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,375 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.75 to $134.79. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| August 30, 2021 Filed Aug 31, 2021 21:13 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionCommon Stock | 3,640 | $41.93 | $152,625.20 |
DisclosureSEC source: 0001127602-21-024594 · form4.xml · nonDerivative · entry 1 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2021 Filed Aug 30, 2021 20:21 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 498 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-21-024541 · form4.xml · derivative · entry 6 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,502 Underlying: Common Stock · 498 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| August 27, 2021 Filed Aug 30, 2021 20:21 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 4,940 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-21-024541 · form4.xml · derivative · entry 5 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,940 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| August 27, 2021 Filed Aug 30, 2021 20:21 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
SaleCommon Stock | 498 | $134.75 | $67,105.50 |
DisclosureSEC source: 0001127602-21-024541 · form4.xml · nonDerivative · entry 4 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,375 Read SEC document |
| August 27, 2021 Filed Aug 30, 2021 20:21 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionCommon Stock | 498 | $41.93 | $20,881.14 |
DisclosureSEC source: 0001127602-21-024541 · form4.xml · nonDerivative · entry 3 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2021 Filed Aug 30, 2021 20:21 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
SaleCommon Stock | 4,940 | $134.78 | $665,797.39 |
DisclosureSEC source: 0001127602-21-024541 · form4.xml · nonDerivative · entry 2 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,375 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.75 to $135.05. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| August 27, 2021 Filed Aug 30, 2021 20:21 UTC |
KENNEDY JOHN JEDGroup Executive Vice President
|
Exercise / conversionCommon Stock | 4,940 | $39.87 | $196,957.80 |
DisclosureSEC source: 0001127602-21-024541 · form4.xml · nonDerivative · entry 1 KENNEDY JOHN JED · CIK 0001287981 · Group Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 13, 2021 Filed Aug 16, 2021 21:48 UTC |
Garner Todd WExecutive Vice President & CFO
|
SaleCommon Stock | 1,350 | $122.76 | $165,726.00 |
DisclosureSEC source: 0001127602-21-023805 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,322 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 15, 2021. Read SEC document |
| June 30, 2021 Filed Jul 6, 2021 13:32 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
GrantCommon Stock | 15 | $130.56 | $1,958.40 |
DisclosureSEC source: 0001127602-21-021405 · form4.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,821 Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 19:04 UTC |
Garner Todd WExecutive Vice President & CFO
|
SaleCommon Stock | 960 | $137.04 | $131,558.40 |
DisclosureSEC source: 0001127602-21-020009 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,672 Read SEC document |
| June 15, 2021 Filed Jun 22, 2021 20:20 UTC Amendment |
Garner Todd WExecutive Vice President & CFO
|
SaleCommon Stock | 960 | $137.04 | $131,558.40 |
DisclosureSEC source: 0001127602-21-020494 · form4a.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,672 F1 · kind: This Amended Form 4 is being filed because the previous Form 4, while correctly noting the shares sold, did not note that the sale had been effected pursuant to a previously adopted 10b5-1 Written Plan. Read SEC document |
| June 11, 2021 Filed Jun 14, 2021 20:06 UTC |
Schwarzentraub Barbara JDirector
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 1,843 | $0.00 Strike: $73.94 | $0.00 |
DisclosureSEC source: 0001127602-21-019780 · form4.xml · derivative · entry 3 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,843 shares Expires 2030-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 11, 2021 Filed Jun 14, 2021 20:06 UTC |
Schwarzentraub Barbara JDirector
|
SaleCommon Stock | 1,843 | $136.90 | $252,312.23 |
DisclosureSEC source: 0001127602-21-019780 · form4.xml · nonDerivative · entry 2 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,416 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.78 to $136.98. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Remove Read SEC document |
| June 11, 2021 Filed Jun 14, 2021 20:06 UTC |
Schwarzentraub Barbara JDirector
|
Exercise / conversionCommon Stock | 1,843 | $73.94 | $136,271.42 |
DisclosureSEC source: 0001127602-21-019780 · form4.xml · nonDerivative · entry 1 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,259 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 20:11 UTC |
Hartman Curt RDirector · President, CEO and Chair
|
SaleCommon Stock | 42,347 | $132.09 | $5,593,488.19 |
DisclosureSEC source: 0001127602-21-019252 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,480 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.00 to $132.83. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:35 UTC |
Workman John LDirector
|
GrantOptions To Purchase Common Stock · Derivative | 865 | $0.00 Strike: $138.45 | $0.00 |
DisclosureSEC source: 0001127602-21-018919 · form4.xml · derivative · entry 4 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 865 Underlying: Common Stock · 865 shares Expires 2031-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:35 UTC |
Workman John LDirector
|
GrantRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018919 · form4.xml · derivative · entry 3 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 812 Underlying: Common Stock · 812 shares Expires 2031-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:35 UTC |
Workman John LDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018919 · form4.xml · derivative · entry 2 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:35 UTC |
Workman John LDirector
|
Exercise / conversionCommon Stock | 1,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018919 · form4.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:31 UTC |
TRYNISKI MARK EDirector
|
GrantOptions To Purchase Common Stock · Derivative | 865 | $0.00 Strike: $138.45 | $0.00 |
DisclosureSEC source: 0001127602-21-018913 · form4.xml · derivative · entry 4 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 865 Underlying: Common Stock · 865 shares Expires 2031-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:31 UTC |
TRYNISKI MARK EDirector
|
GrantRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018913 · form4.xml · derivative · entry 3 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 812 Underlying: Common Stock · 812 shares Expires 2031-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:31 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018913 · form4.xml · derivative · entry 2 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:31 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionCommon Stock | 1,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018913 · form4.xml · nonDerivative · entry 1 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,410 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:27 UTC |
Schwarzentraub Barbara JDirector
|
GrantOptions To Purchase Common Stock · Derivative | 865 | $0.00 Strike: $138.45 | $0.00 |
DisclosureSEC source: 0001127602-21-018908 · form4.xml · derivative · entry 4 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 865 Underlying: Common Stock · 865 shares Expires 2031-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:27 UTC |
Schwarzentraub Barbara JDirector
|
GrantRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018908 · form4.xml · derivative · entry 3 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 812 Underlying: Common Stock · 812 shares Expires 2031-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:27 UTC |
Schwarzentraub Barbara JDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018908 · form4.xml · derivative · entry 2 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:27 UTC |
Schwarzentraub Barbara JDirector
|
Exercise / conversionCommon Stock | 1,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018908 · form4.xml · nonDerivative · entry 1 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:22 UTC |
Lande Jerome J.Director
|
GrantOptions To Purchase Common Stock · Derivative | 865 | $0.00 Strike: $138.45 | $0.00 |
DisclosureSEC source: 0001127602-21-018903 · form4.xml · derivative · entry 4 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 865 Underlying: Common Stock · 865 shares Expires 2031-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:22 UTC |
Lande Jerome J.Director
|
GrantRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018903 · form4.xml · derivative · entry 3 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 812 Underlying: Common Stock · 812 shares Expires 2031-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:22 UTC |
Lande Jerome J.Director
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018903 · form4.xml · derivative · entry 2 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:22 UTC |
Lande Jerome J.Director
|
Exercise / conversionCommon Stock | 1,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018903 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:03 UTC |
Council LaVerne HDirector
|
GrantOptions To Purchase Common Stock · Derivative | 865 | $0.00 Strike: $138.45 | $0.00 |
DisclosureSEC source: 0001127602-21-018897 · form4.xml · derivative · entry 4 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 865 Underlying: Common Stock · 865 shares Expires 2031-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:03 UTC |
Council LaVerne HDirector
|
GrantRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018897 · form4.xml · derivative · entry 3 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 812 Underlying: Common Stock · 812 shares Expires 2031-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:03 UTC |
Council LaVerne HDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018897 · form4.xml · derivative · entry 2 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:03 UTC |
Council LaVerne HDirector
|
Exercise / conversionCommon Stock | 1,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018897 · form4.xml · nonDerivative · entry 1 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:13 UTC |
Farkas CharlesDirector
|
GrantOptions To Purchase Common Stock · Derivative | 865 | $0.00 Strike: $138.45 | $0.00 |
DisclosureSEC source: 0001127602-21-018898 · form4.xml · derivative · entry 4 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 865 Underlying: Common Stock · 865 shares Expires 2031-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:13 UTC |
Farkas CharlesDirector
|
GrantRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018898 · form4.xml · derivative · entry 3 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 812 Underlying: Common Stock · 812 shares Expires 2031-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:13 UTC |
Farkas CharlesDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018898 · form4.xml · derivative · entry 2 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 18:13 UTC |
Farkas CharlesDirector
|
Exercise / conversionCommon Stock | 1,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018898 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,431 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 17:55 UTC |
Concannon BrianDirector
|
GrantOptions To Purchase Common Stock · Derivative | 865 | $0.00 Strike: $138.45 | $0.00 |
DisclosureSEC source: 0001127602-21-018896 · form4.xml · derivative · entry 4 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 865 Underlying: Common Stock · 865 shares Expires 2031-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 17:55 UTC |
Concannon BrianDirector
|
GrantRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018896 · form4.xml · derivative · entry 3 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 812 Underlying: Common Stock · 812 shares Expires 2031-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 17:55 UTC |
Concannon BrianDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,521 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018896 · form4.xml · derivative · entry 2 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,521 shares Expires 2030-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 17:55 UTC |
Concannon BrianDirector
|
Exercise / conversionCommon Stock | 1,521 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018896 · form4.xml · nonDerivative · entry 1 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 17:48 UTC |
Bronson David M.Director
|
GrantOptions To Purchase Common Stock · Derivative | 865 | $0.00 Strike: $138.45 | $0.00 |
DisclosureSEC source: 0001127602-21-018894 · form4.xml · derivative · entry 4 BRONSON DAVID M · CIK 0001183762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 865 Underlying: Common Stock · 865 shares Expires 2031-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.